Michael J. Kelner
University of California San Diego
San Diego
CA 92103
USA
Name/email consistency: high
- Synergy of irofulven in combination with other DNA damaging agents: synergistic interaction with altretamine, alkylating, and platinum-derived agents in the MV522 lung tumor model. Kelner, M.J., McMorris, T.C., Rojas, R.J., Estes, L.A., Suthipinijtham, P. Cancer Chemother. Pharmacol. (2008)
- Synergy of Irofulven in combination with various anti-metabolites, enzyme inhibitors, and miscellaneous agents in MV522 lung carcinoma cells: marked interaction with gemcitabine and 5-fluorouracil. Kelner, M.J., McMorris, T.C., Rojas, R.J., Estes, L.A., Suthipinijtham, P. Invest. New. Drugs (2008)
- Structural organization of the murine microsomal glutathione S-transferase gene (MGST1) from the 129/SvJ strain: identification of the promoter region and a comprehensive examination of tissue expression. Kelner, M.J., Bagnell, R.D., Morgenstern, R. Biochim. Biophys. Acta (2004)
- Enhanced antitumor activity of irofulven in combination with thiotepa or mitomycin C. Kelner, M.J., McMorris, T.C., Rojas, R.J., Trani, N.A., Estes, L. Cancer Chemother. Pharmacol. (2002)
- Enhanced antitumor activity of irofulven in combination with antimitotic agents. Kelner, M.J., McMorris, T.C., Rojas, R.J., Trani, N.A., Velasco, T.R., Estes, L.A., Suthipinijtham, P. Invest. New. Drugs (2002)
- Structural organization of the human glutathione reductase gene: determination of correct cDNA sequence and identification of a mitochondrial leader sequence. Kelner, M.J., Montoya, M.A. Biochem. Biophys. Res. Commun. (2000)
- Structural organization of the microsomal glutathione S-transferase gene (MGST1) on chromosome 12p13.1-13.2. Identification of the correct promoter region and demonstration of transcriptional regulation in response to oxidative stress. Kelner, M.J., Bagnell, R.D., Montoya, M.A., Estes, L.A., Forsberg, L., Morgenstern, R. J. Biol. Chem. (2000)
- Structural organization of the human gastrointestinal glutathione peroxidase (GPX2) promoter and 3'-nontranscribed region: transcriptional response to exogenous redox agents. Kelner, M.J., Bagnell, R.D., Montoya, M.A., Lanham, K.A. Gene (2000)
- Efficacy of MGI 114 (HMAF) against the MRP+ metastatic MV522 lung carcinoma xenograft. Kelner, M.J., McMorris, T.C., Estes, L.A., Oval, M.Y., Rojas, R.J., Lynn, J.R., Lanham, K.A., Samson, K.M. Anticancer. Drugs (2000)
- Characterization of MGI 114 (HMAF) histiospecific toxicity in human tumor cell lines. Kelner, M.J., McMorris, T.C., Montoya, M.A., Estes, L., Uglik, S.F., Rutherford, M., Samson, K.M., Bagnell, R.D., Taetle, R. Cancer Chemother. Pharmacol. (1999)
- Characterization of acylfulvene histiospecific toxicity in human tumor cell lines. Kelner, M.J., McMorris, T.C., Montoya, M.A., Estes, L., Uglik, S.F., Rutherford, M., Samson, K.M., Bagnell, R.D., Taetle, R. Cancer Chemother. Pharmacol. (1998)
- Structural organization of the human selenium-dependent phospholipid hydroperoxide glutathione peroxidase gene (GPX4): chromosomal localization to 19p13.3. Kelner, M.J., Montoya, M.A. Biochem. Biophys. Res. Commun. (1998)
- Heterologous expression of carbonyl reductase: demonstration of prostaglandin 9-ketoreductase activity and paraquat resistance. Kelner, M.J., Estes, L., Rutherford, M., Uglik, S.F., Peitzke, J.A. Life Sci. (1997)
